Patents
Patents for C07K 17 - Carrier-bound or immobilised peptides; Preparation thereof (10,673)
01/2008
01/08/2008US7317074 PRO polypeptides; fusion proteins; immunoglobulins; cytokines; for stimulating release of tumor necrosis factor from blood; for modulating uptake of glucose by adipocyte cells; for release of proteoglycans from cartilage
01/08/2008US7317002 Site-specific preparation of polyethylene glycol-GRF conjugates
01/08/2008US7317000 Glucose-dependent insulins
01/08/2008US7316919 Composite materials comprising supported porous gels
01/03/2008WO2005032476A3 Methods and compositions for cpg15-2
01/03/2008US20080004398 Bioactive Biomaterials for Controlled Delivery of Active Principles
01/02/2008EP1871804A2 Reagents that bind ccx-ckr2
01/02/2008EP1499346B1 Treatment of type 1 diabetes before and after expression of predisposition markers
01/01/2008US7314920 Antibodies against the PRO4340 polypeptide
01/01/2008US7314918 PRO6246 antibodies
01/01/2008US7314916 HER3 (human epidermal growth factor receptor 3) variant polypeptides having amino acid sequences which differ from the native HER3 polypeptide sequence and which have altered affinities for heregulin; for in vitro, in situ, and/or in vivo diagnosis and/or treatment
01/01/2008US7314913 PRO1891 polypeptides
01/01/2008US7314724 Therapeutic applications of laminin and laminin-derived protein fragments
01/01/2008US7314613 Covalently attached to a nonpeptide moiety; nucleic acids encoding the polypeptides; reducing the number of copies of a virus in infected cells
12/2007
12/27/2007WO2007149490A1 Processes for recovering stabilized formulations of trimers of retroviral envelope (env) proteins
12/27/2007WO2007109118A9 RECOMBINANT HUMAN CC 10 (rhCC10) FOR TREATMENT OF RESPIRATORY DISORDERS
12/27/2007US20070298432 Binding Assay Components
12/27/2007US20070297982 Preparation And Composition Of Inter-Alpha Inhibitor Proteins From Human Plasma For Therapeutic Use
12/27/2007CA2655929A1 Processes for recovering stabilized formulations of trimers of retroviral envelope (env) proteins
12/27/2007CA2653061A1 Stabilized proteins
12/26/2007EP1870417A2 Peptide acceptor ligation methods
12/26/2007EP1869088A2 Compounds and methods for peptide synthesis
12/26/2007EP1869066A1 Peptide synthesis of alpha-helixes on peg resin
12/26/2007EP0867190B1 Cytotoxin complexes comprising dipeptides
12/25/2007US7312316 Novel polypeptides and nucleic acid molecules encoding those polypeptides; vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides fused to heterologous polypeptide sequences, and antibodies which bind to the polypeptides
12/25/2007US7312315 PRO9742 antibodies
12/25/2007US7312314 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes by contacting blood with polypeptide; cancer diagnosis
12/25/2007US7312313 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and tumor disorders
12/25/2007US7312312 PRO6242 polypeptides
12/25/2007US7312309 For release of tumor necrosis and or cellular differentation/proliferation of chrondrocytes by contacting blood w/polypeptides; cancer diagnosis
12/25/2007US7312308 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocyte/pericyte/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis
12/25/2007US7312192 For treating diseases including diabetes
12/25/2007US7312057 Method for reducing binding of organic material to hydrophobic surfaces
12/25/2007US7311909 PRO4348 antibodies
12/25/2007US7311903 Recombinant cytokine for use in treatment of viral infection and cell proliferative disorders
12/21/2007CA2654840A1 Biomolecule-linked biomimetic scaffolds
12/20/2007US20070293659 Immobilization of glycoproteins
12/19/2007EP1866077A1 Polymer entrapped particles
12/19/2007CN100355786C Polyethylene glycol-modified thymus peptide 1 derivatives
12/19/2007CN100355784C Method for preparing polyethylene glycol-modified alpha-interferon 1b
12/18/2007US7309778 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/18/2007US7309777 Antibodies against the PRO1556 polypeptide
12/18/2007US7309776 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of cell proliferative and tumor disorders
12/18/2007US7309771 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of tumors
12/18/2007US7309768 PRO4347 polypeptides
12/18/2007US7309767 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
12/18/2007US7309765 PRO4349 polypeptides
12/18/2007US7309764 PRO4401 polypeptide
12/18/2007US7309763 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and tumor disorders
12/18/2007US7309759 Indolicidin peptide analogues containing at least two basic amino acids; bactericide
12/18/2007US7309488 capable of efficient and selective adsorption of an antibody against beta 1-adrenoceptor and/or an antibody against M2 muscarinic receptor occurring in a body fluid (e.g. blood, plasma or the like) without requiring a pretreatment
12/13/2007WO2007143161A2 Use of proteins and peptides of the tgf-beta superfamily for purification and therapeutic methods
12/13/2007WO2007140768A1 Protein biochip for the differential screening of protein-protein interactions
12/13/2007WO2007140545A1 Methods of diagnosis and treatment of m. tuberculosis infection and reagents therefore
12/13/2007WO2006076255A3 Method of treating or preventing microbial eye infection
12/13/2007CA2654181A1 Use of proteins and peptides of the tgf-beta superfamily for purification and therapeutic methods
12/12/2007EP1863844A1 Heterodimeric protein binding compositions
12/12/2007EP0888377B1 MURINE alpha(1,3)-FUCOSYLTRANSFERASE (Fuc-TVII)
12/12/2007CN100354284C Preparation of triazoline artificial semi-antigen, antigen and antibody
12/11/2007US7307150 Dextran-hemoglobin conjugates as blood substitutes
12/11/2007US7307149 Recombinant cellulose synthase for use as tool in enhancing plant nodal and stalk strength; improving ethanol biosynthesis
12/11/2007US7307144 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders
12/11/2007US7306945 Fragment of alpha-synuclein is contacted with a drug; reduction in the rate or extent of aggregation fragment of alpha-synuclein relative to a control lacking the agent indicates the agent has the pharmacological activity
12/11/2007US7306934 Porous solid ion exchange wafer for immobilizing biomolecules
12/11/2007US7306923 Methods for identification, and compounds useful for the treatment of degenerative & inflammatory diseases
12/11/2007US7306795 PRO5774 antibodies
12/11/2007US7306791 Comprising Tumor cytotoxic factor-II or Hepatocyte growth factor as an effective ingredient
12/11/2007US7306782 Method for the production of conjugates and uses thereof for the prevention and treatment of allergic reactions and autoimmune diseases
12/06/2007WO2007139397A1 Ob fold domains
12/06/2007WO2007002534A3 Thrombospondin-1 derived peptides and treatment methods
12/06/2007WO2004060304A3 Novel compositions and methods in cancer
12/06/2007US20070280946 Antibody to 5' -Deoxy-5' - Methylthioadenosine And Uses Thereof
12/06/2007CA2653752A1 Ob fold domains
12/06/2007CA2653080A1 Compositions and methods for the delivery of oxygen
12/05/2007EP1862546A1 Enhanced virus-mediated dna transfer
12/05/2007EP1861416A1 Obestatin and its uses
12/05/2007EP1635692A4 Monitoring immunologic, hematologic and inflammatory diseases
12/05/2007CN101083907A Compositions and methods for topical diagnostic and therapeutic transport
12/04/2007US7304140 For stimulating release of tumor necrosis factor, and/or cellular proliferation/differentiation of chondrocytes/pericytes/adipocytes/endothelial cells by contacting blood with polypeptide; cancer diagnosis
12/04/2007US7304135 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders
12/04/2007US7304134 PRO9742 polypeptides
12/04/2007US7304128 High affinity and specificity, separation and immobilization of these structures for the fabrication of nano-devices
12/04/2007US7303886 High throughput cell-based functional assays and using cells, e.g., HEK-293 cells that express a G protein such as G alpha 15, G alpha 16 or gustducin.
12/04/2007CA2199145C Novel n3s2 chelating ligands optionally radiolabelled with tc or re, useful for diagnostic or therapeutic applications
11/2007
11/29/2007WO2007084977A3 Low hemoglobin concentration cell percentage and method of use in detection of iron deficiency
11/29/2007WO2007061657A3 Interleukin-10 compositions for the treatment of adenocarcinomas
11/29/2007WO2005010198A3 Protein logic gates
11/29/2007US20070275890 Chaperonin 10 Modulation Of Toll-Like Receptor-Inducible Cytokine And Chemokine Secretion
11/29/2007US20070275420 Method For Detecting Prognosis Of Cancer
11/29/2007US20070274950 Interferon-alpha polypeptides and conjugates
11/28/2007EP1859277A2 Treating neurological disorders
11/28/2007EP1859266A2 Compositions and methods for classifying biological samples
11/28/2007EP0959682B1 Therapeutic applications of laminin and laminin-derived protein fragments
11/28/2007CN101077888A Polyethylene glycol modified neurotoxin, preparation method and use thereof
11/27/2007US7301009 Isolated (T1R1/T1R3) umami taste receptors that respond to umami taste stimuli
11/27/2007US7301007 PRO4340 polypeptides
11/22/2007WO2007132037A1 Method for synthesizing thymosins
11/22/2007WO2007056525A3 High affinity siglec ligands
11/22/2007WO2003041483A3 Method to study and mechanisms of biofilm-related antibiotic resistance
11/22/2007WO2003006672A3 Antimicrobial nucleic acid antibodies, and materials and methods for making and using same
1 ... 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 ... 107